GLP-1 obesity medications, such as Ozempic and Wegovy, play a significant role in weight management, but their effectiveness varies among individuals. Researchers at the University of Alberta are exploring the impact of energy metabolism and individual factors on the success of…
Comedian Kim Jun Ho recently shared his experience losing 7kg with GLP-1 obesity medication, but he also warned about the risk of weight regain if lifestyle changes are not mainta…
A recent Phase 3 trial of the experimental obesity medication retatrutide demonstrated an average weight loss of 25% at the highest dose over 80 weeks, along with improvements in…
Access to obesity drugs in the UK is divided between a slow NHS rollout of tirzepatide and a rapidly growing private market. The NHS aims to provide access over 12 years, starting…
A new Scientific Statement from the Endocrine Society underscores the importance of focusing on health improvements rather than solely on weight loss in obesity treatment. The sta…
The article highlights the historical separation between the fields of eating disorders and obesity, emphasizing the need for a collaborative approach to improve patient assessmen…
As obesity medications evolve, researchers are exploring new hormone combinations to enhance treatment effectiveness and tolerability. Current studies focus on therapies that not…
New research from Yale University has uncovered surprising effects of Ozempic, a GLP-1 medication, on hunger neurons in the brain. Contrary to previous beliefs that these neurons…
Researchers at the University of Cambridge have discovered that both activating and blocking the glucose-dependent insulinotropic polypeptide receptor (GIPR) in different brain re…
The Health Products Regulatory Authority (HPRA) has confirmed over 1,500 reports of suspected adverse reactions related to anti-obesity medications, including serious gastrointest…
A recent study from Yale University has uncovered a surprising mechanism by which GLP-1 therapies, like Ozempic, support sustained weight loss. Contrary to previous beliefs that t…
A recent study reveals that meal timing significantly affects circadian rhythms in the dorsal vagal complex (DVC), a critical brainstem region involved in satiety. The findings in…
The beauty industry is racing to develop innovative treatments for consumers concerned about facial sagging caused by quick weight loss associated with popular obesity medications.